Exchange: OTC Sector: Healthcare Industry: Biotechnology
17.95% $2.30
America/New_York / 3 mai 2024 @ 10:01
FUNDAMENTALS | |
---|---|
MarketCap: | 85.86 mill |
EPS: | -0.0170 |
P/E: | -135.29 |
Earnings Date: | Jul 22, 2024 |
SharesOutstanding: | 37.33 mill |
Avg Daily Volume: | 0.0001 mill |
RATING 2024-05-03 |
---|
C- |
Strong Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Strong Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | n/a | n/a | n/a | |||
Gr.Profit | n/a | n/a | ||||
Ebit | ||||||
Asset | ||||||
Debt | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -135.29 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.99x |
Company: PE -135.29 | industry: PE 136.10 |
DISCOUNTED CASH FLOW VALUE |
---|
$-0.899 (-139.10%) $-3.20 |
Date: 2024-05-05 |
Expected Trading Range (DAY) |
---|
$ 2.16 - 2.44 ( +/- 6.26%) |
ATR Model: 14 days |